1. Home
  2. ALDX
  3. ALDX News

Latest Aldeyra Therapeutics Inc. (ALDX) News on November 24, 2024

Top US Penny Stocks To Watch In November 2024
ALDX

Simply Wall St.

4 days ago

Top US Penny Stocks To Watch In November 2024

ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
ALDX

Zacks

5 days ago

ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap

ALDX

MT Newswires

6 days ago

Aldeyra Therapeutics' Resubmitted Marketing Application for Eye Disease Drug Accepted by FDA

ALDX

Business Wire

6 days ago

Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement

ALDX

Business Wire

10 days ago

Aldeyra Therapeutics to Participate in the Jefferies London Healthcare Conference

Is BellRing Brands (BRBR) Outperforming Other Medical Stocks This Year?
ALDX

Zacks

12 days ago

Is BellRing Brands (BRBR) Outperforming Other Medical Stocks This Year?

ALDX

Business Wire

24 days ago

Aldeyra Therapeutics Selected to Present at the Disruptive Innovations Symposium during the OSN New York Retina 2024 Meeting

ALDX

MT Newswires

2 months ago

Aldeyra Therapeutics Resubmits New Drug Application for Dry Eye Disease Treatment Candidate

ALDX

Business Wire

2 months ago

Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease

ALDX

Business Wire

3 months ago

Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

High Growth Tech Stocks To Watch In The United States
ALDX

Simply Wall St.

3 months ago

High Growth Tech Stocks To Watch In The United States

Aldeyra Therapeutics Inc (NASDAQ:ALDX) A Bull Case Theory
ALDX

Insider Monkey

3 months ago

Aldeyra Therapeutics Inc (NASDAQ:ALDX) A Bull Case Theory

Aldeyra’s Phase III clinical trial of Reproxalap meets primary endpoint
ALDX

Clinical Trials Arena

3 months ago

Aldeyra’s Phase III clinical trial of Reproxalap meets primary endpoint

Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap
ALDX

Business Wire

4 months ago

Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap

ALDX

Business Wire

4 months ago

Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from the Phase 3 Dry Eye Chamber Clinical Trial of Reproxalap

Owning 36% shares,institutional owners seem interested in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX),
ALDX

Simply Wall St.

4 months ago

Owning 36% shares,institutional owners seem interested in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX),

Aldeyra Therapeutics Announces Advancement of New RASP Modulators and Recent Preclinical Data in Obesity at 2024 Investor Roundtable
ALDX

Business Wire

5 months ago

Aldeyra Therapeutics Announces Advancement of New RASP Modulators and Recent Preclinical Data in Obesity at 2024 Investor Roundtable

Aldeyra Therapeutics concludes subject enrolment in dry eye disease trial
ALDX

Clinical Trials Arena

5 months ago

Aldeyra Therapeutics concludes subject enrolment in dry eye disease trial

Aldeyra Therapeutics Completes Enrollment in Phase 3 Clinical Trial of Reproxalap in Dry Eye Disease
ALDX

Business Wire

5 months ago

Aldeyra Therapeutics Completes Enrollment in Phase 3 Clinical Trial of Reproxalap in Dry Eye Disease

ALDX

Business Wire

5 months ago

Aldeyra Therapeutics to Host Investor Roundtable Q&A

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
ALDX

CNW Group

5 months ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
ALDX

PR Newswire

5 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store
ALDX

Business Wire

5 months ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts
ALDX

AFP

5 months ago

New Zealand scraps plan to tax livestock burps, farts

ALDX

Business Wire

5 months ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility
ALDX

The Wall Street Journal

5 months ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

UK Unemployment Rises in Sign Inflationary Pressures Cool
ALDX

Bloomberg

5 months ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024
ALDX

Simply Wall St.

5 months ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

ALDX

Business Wire

6 months ago

Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference

Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?
ALDX

Zacks

6 months ago

Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?

ALDX

MT Newswires

7 months ago

Aldeyra Therapeutics Enrolls First Patient in Phase 3 Dry Eye Chamber Study

ALDX

Business Wire

7 months ago

Aldeyra Therapeutics Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease

Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day
ALDX

Business Wire

7 months ago

Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day

Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?
ALDX

Zacks

7 months ago

Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?

ALDX

Business Wire

7 months ago

Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024

Aldeyra (ALDX) Stock Rallies 43% in One Week: Here's Why
ALDX

Zacks

8 months ago

Aldeyra (ALDX) Stock Rallies 43% in One Week: Here's Why

Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?
ALDX

Zacks

8 months ago

Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?

Health Care Roundup: Market Talk
ALDX

The Wall Street Journal

8 months ago

Health Care Roundup: Market Talk

Aldeyra's Dry Eye Disease Drug May Be on Path for FDA Approval
ALDX

Barrons.com

8 months ago

Aldeyra's Dry Eye Disease Drug May Be on Path for FDA Approval

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Is About To Turn The Corner
ALDX

Simply Wall St.

8 months ago

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Is About To Turn The Corner

ALDX

Business Wire

8 months ago

Aldeyra Therapeutics Announces Clinical Development Plan for Resubmission of New Drug Application for Reproxalap in Dry Eye Disease

Aldeyra Therapeutics Inc President and CEO Todd Brady Sells Company Shares
ALDX

GuruFocus.com

8 months ago

Aldeyra Therapeutics Inc President and CEO Todd Brady Sells Company Shares

Here's Why You Should Invest in Aldeyra (ALDX) Stock Now
ALDX

Zacks

9 months ago

Here's Why You Should Invest in Aldeyra (ALDX) Stock Now

Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year?
ALDX

Zacks

9 months ago

Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year?

Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics
ALDX

Zacks

9 months ago

Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics

5 Small Drug Stocks to Buy From a Rebounding Industry
ALDX

Zacks

9 months ago

5 Small Drug Stocks to Buy From a Rebounding Industry

Institutions own 37% of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) shares but retail investors control 37% of the company
ALDX

Simply Wall St.

9 months ago

Institutions own 37% of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) shares but retail investors control 37% of the company

ALDX

Business Wire

10 months ago

Aldeyra Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Orchid Island Capital, Inc. (NYSE:ORC) Q4 2023 Earnings Call Transcript
ALDX

Insider Monkey

10 months ago

Orchid Island Capital, Inc. (NYSE:ORC) Q4 2023 Earnings Call Transcript

ALDX

Associated Press Finance

10 months ago

Waterstone: Q4 Earnings Snapshot

AdTheorent Recognized as Leading Innovator in Frost Radar™ Featuring Demand-Side Platforms
ALDX

PR Newswire

10 months ago

AdTheorent Recognized as Leading Innovator in Frost Radar™ Featuring Demand-Side Platforms

Sierra Bancorp Reports Strategic Securities Transaction as Well as Fourth Quarter and Year End 2023 Results
ALDX

Business Wire

10 months ago

Sierra Bancorp Reports Strategic Securities Transaction as Well as Fourth Quarter and Year End 2023 Results

Ramaco Resources (NASDAQ:METC) Is Increasing Its Dividend To $0.1375
ALDX

Simply Wall St.

10 months ago

Ramaco Resources (NASDAQ:METC) Is Increasing Its Dividend To $0.1375

ALDX

GuruFocus.com

10 months ago

South Plains Financial Inc. Reports Mixed Results Amid Economic Challenges

ALDX

Associated Press Finance

10 months ago

South Plains Financial: Q4 Earnings Snapshot

South Plains Financial, Inc. Reports Fourth Quarter and Year-End 2023 Financial Results
ALDX

GlobeNewswire

10 months ago

South Plains Financial, Inc. Reports Fourth Quarter and Year-End 2023 Financial Results

ALDX

Associated Press Finance

10 months ago

Northfield: Q4 Earnings Snapshot

Northfield Bancorp, Inc. Announces the Appointment of Dr. Rachana A. Kulkarni to Its Board of Directors
ALDX

GlobeNewswire

10 months ago

Northfield Bancorp, Inc. Announces the Appointment of Dr. Rachana A. Kulkarni to Its Board of Directors

McEwen (MUX) Loses -13.83% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ALDX

Zacks

10 months ago

McEwen (MUX) Loses -13.83% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

CANOPY GROWTH KICKS OFF THE NEW YEAR WITH NEW PRODUCTS FROM TWEED, 7ACRES, AND SPECTRUM THERAPEUTICS
ALDX

CNW Group

10 months ago

CANOPY GROWTH KICKS OFF THE NEW YEAR WITH NEW PRODUCTS FROM TWEED, 7ACRES, AND SPECTRUM THERAPEUTICS

Unpacking Q3 Earnings: BJ's (NASDAQ:BJRI) In The Context Of Other Sit-Down Dining Stocks
ALDX

StockStory

10 months ago

Unpacking Q3 Earnings: BJ's (NASDAQ:BJRI) In The Context Of Other Sit-Down Dining Stocks

A Look Back at Consumer Internet Stocks' Q3 Earnings: Skillz (NYSE:SKLZ) Vs The Rest Of The Pack
ALDX

StockStory

10 months ago

A Look Back at Consumer Internet Stocks' Q3 Earnings: Skillz (NYSE:SKLZ) Vs The Rest Of The Pack

Those who invested in Mistras Group (NYSE:MG) a year ago are up 50%
ALDX

Simply Wall St.

10 months ago

Those who invested in Mistras Group (NYSE:MG) a year ago are up 50%

Park Aerospace Corp. Reports Third Quarter Results
ALDX

GlobeNewswire

10 months ago

Park Aerospace Corp. Reports Third Quarter Results

Aldeyra Therapeutics Provides Clinical and Regulatory Update and Announces Advancement of RASP Platform in Systemic and Retinal Inflammatory Diseases
ALDX

Business Wire

a year ago

Aldeyra Therapeutics Provides Clinical and Regulatory Update and Announces Advancement of RASP Platform in Systemic and Retinal Inflammatory Diseases

Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ALDX

Business Wire

a year ago

Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

ALDX

Business Wire

a year ago

Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds

NeuroPace Inc Chief Medical Officer Martha Morrell Sells 13,402 Shares
ALDX

GuruFocus.com

a year ago

NeuroPace Inc Chief Medical Officer Martha Morrell Sells 13,402 Shares

Amicus (FOLD) Banks on Galafold, Overdependence a Concern
ALDX

Zacks

a year ago

Amicus (FOLD) Banks on Galafold, Overdependence a Concern

Sight Sciences Announces Withdrawal of Final LCDs on Micro-Invasive Glaucoma Surgery from Five Medicare Administrative Contractors
ALDX

GlobeNewswire

a year ago

Sight Sciences Announces Withdrawal of Final LCDs on Micro-Invasive Glaucoma Surgery from Five Medicare Administrative Contractors

Is It Smart To Buy Northeast Community Bancorp, Inc. (NASDAQ:NECB) Before It Goes Ex-Dividend?
ALDX

Simply Wall St.

a year ago

Is It Smart To Buy Northeast Community Bancorp, Inc. (NASDAQ:NECB) Before It Goes Ex-Dividend?

Karuna downgraded, Arm target raised: Wall Street's top analyst calls
ALDX

The Fly

a year ago

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

With EPS Growth And More, Kimball Electronics (NASDAQ:KE) Makes An Interesting Case
ALDX

Simply Wall St.

a year ago

With EPS Growth And More, Kimball Electronics (NASDAQ:KE) Makes An Interesting Case

Entravision Communications Corporation's (NYSE:EVC) Stock Is Going Strong: Have Financials A Role To Play?
ALDX

Simply Wall St.

a year ago

Entravision Communications Corporation's (NYSE:EVC) Stock Is Going Strong: Have Financials A Role To Play?

ALDX

Business Wire

a year ago

Certain Eaton Vance Municipal Closed-End Funds Announce Distribution Updates

Unity Bank Provides Multimillion Construction Loan for Clinton 122-Unit Assisted Living & Memory Care Center
ALDX

GlobeNewswire

a year ago

Unity Bank Provides Multimillion Construction Loan for Clinton 122-Unit Assisted Living & Memory Care Center

NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study
ALDX

GlobeNewswire

a year ago

NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study

ALDX

Business Wire

a year ago

First Trust Energy Infrastructure Fund Declares its Monthly Common Share Distribution of $0.10 Per Share for January

EPIX: Initial Data from Combination Trial of Masofaniten and Enzalutamide Expected in 2024…
ALDX

Zacks Small Cap Research

a year ago

EPIX: Initial Data from Combination Trial of Masofaniten and Enzalutamide Expected in 2024…

Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.22 per Share for Q4 2023
ALDX

GlobeNewswire

a year ago

Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.22 per Share for Q4 2023

ALDX

Reuters

a year ago

UPDATE 1-Aldeyra Therapeutics' skin disease drug succeeds in mid-stage study

ALDX

Reuters

a year ago

Aldeyra Therapeutics' eczema drug succeeds in mid-stage study

ALDX

Business Wire

a year ago

Aldeyra Therapeutics Announces Statistically and Clinically Significant Improvement from Baseline in Phase 2 Clinical Trial of ADX‑629 in Patients with Atopic Dermatitis

ALDX

Business Wire

a year ago

Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from Phase 2 Clinical Trial of ADX-629 in Patients with Atopic Dermatitis

First Trust Energy Infrastructure Fund Issues Notice Regarding December 2023 Distribution
ALDX

Business Wire

a year ago

First Trust Energy Infrastructure Fund Issues Notice Regarding December 2023 Distribution

Arteris Inc CFO Nicholas Hawkins Sells 20,000 Shares: An Insider Sell Analysis
ALDX

GuruFocus.com

a year ago

Arteris Inc CFO Nicholas Hawkins Sells 20,000 Shares: An Insider Sell Analysis

Why Cassava Sciences Stock Soared Today
ALDX

Motley Fool

a year ago

Why Cassava Sciences Stock Soared Today

13 Hot Penny Stocks To Buy According to Hedge Funds
ALDX

Insider Monkey

a year ago

13 Hot Penny Stocks To Buy According to Hedge Funds

Semtech (SMTC) to Release Q3 Earnings: What's in the Cards?
ALDX

Zacks

a year ago

Semtech (SMTC) to Release Q3 Earnings: What's in the Cards?

Should You Buy Aldeyra Therapeutics (ALDX) Ahead of Earnings?
ALDX

Zacks

a year ago

Should You Buy Aldeyra Therapeutics (ALDX) Ahead of Earnings?

Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at November 30, 2023
ALDX

GlobeNewswire

a year ago

Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at November 30, 2023

Canaan Inc. (NASDAQ:CAN) Q3 2023 Earnings Call Transcript
ALDX

Insider Monkey

a year ago

Canaan Inc. (NASDAQ:CAN) Q3 2023 Earnings Call Transcript

Does Caribou Biosciences, Inc. (CRBU) Have the Potential to Rally 321.46% as Wall Street Analysts Expect?
ALDX

Zacks

a year ago

Does Caribou Biosciences, Inc. (CRBU) Have the Potential to Rally 321.46% as Wall Street Analysts Expect?

American Well Corporation (AMWL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
ALDX

Zacks

a year ago

American Well Corporation (AMWL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Sidoti Events, LLC’s Virtual November Micro-Cap Conference
ALDX

ACCESSWIRE

a year ago

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

Newegg Introduces Group Buy to Reward Customers Who Come Together to Unlock Special Daily Deals
ALDX

Business Wire

a year ago

Newegg Introduces Group Buy to Reward Customers Who Come Together to Unlock Special Daily Deals

Investing in Nature's Sunshine Products (NASDAQ:NATR) a year ago would have delivered you a 108% gain
ALDX

Simply Wall St.

a year ago

Investing in Nature's Sunshine Products (NASDAQ:NATR) a year ago would have delivered you a 108% gain

Cricut, Inc. Reports Third Quarter 2023 Financial Results
ALDX

GlobeNewswire

a year ago

Cricut, Inc. Reports Third Quarter 2023 Financial Results

Nayax Reports Third Quarter 2023 Financial Results
ALDX

GlobeNewswire

a year ago

Nayax Reports Third Quarter 2023 Financial Results

Immutep Announces Completion of the Safety Lead-In and Opening of the Randomized Phase II of the AIPAC-003 Phase II/III Trial in Metastatic Breast Cancer
ALDX

GlobeNewswire

a year ago

Immutep Announces Completion of the Safety Lead-In and Opening of the Randomized Phase II of the AIPAC-003 Phase II/III Trial in Metastatic Breast Cancer

Share on Social Networks: